03/14 | Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemi.. | BU |
03/01 | IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, .. | BU |
02/24 | IFPW Launches Environmental, Social, and Corporate Governance (ESG) Framework To Serve .. | AQ |
02/23 | IQVIA Publishes its 2022 Environmental, Social and Governance Report | BU |
02/15 | IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
02/13 | Iqvia Holdings Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin.. | AQ |
02/13 | IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance | AQ |
02/10 | Iqvia : Quarterly Earnings Documents | PU |
02/10 | Iqvia : Q4 Earnings Snapshot | AQ |
02/10 | IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance | BU |
02/09 | IQVIA Named to FORTUNE's 2023 List of “World's Most Admired Companies,” Ran.. | BU |
01/31 | IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in.. | BU |
01/25 | IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 | BU |
01/18 | Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA In.. | BU |
01/03 | Lasso announces a significant step forward in healthcare marketing measurement | PR |
2022 | Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal D.. | AQ |
2022 | IQVIA and Clalit Health Services partner to advance research by launching the first Pri.. | BU |
2022 | IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
2022 | Iqvia : Q3 Earnings Snapshot | AQ |
2022 | IQVIA Reports Third-Quarter 2022 Results | BU |
2022 | IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on Novem.. | BU |
2022 | Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With.. | BU |
2022 | IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022 | BU |
2022 | Iqvia Holdings Inc. : Change in Directors or Principal Officers (form 8-K) | AQ |
2022 | IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation | BU |
2022 | New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials | BU |
2022 | IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2.. | BU |
2022 | IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference .. | BU |
2022 | IQVIA Wins Snowflake's “Marketplace Healthcare and Life Sciences Partner of the Y.. | BU |
2022 | Iqvia Holdings Inc. : Change in Directors or Principal Officers (form 8-K) | AQ |
2022 | IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
2022 | Iqvia : Reports Second-Quarter 2022 Results - Form 8-K | PU |
2022 | Iqvia : Q2 Earnings Snapshot | AQ |
2022 | Iqvia Holdings Inc. : Results of Operations and Financial Condition (form 8-K) | AQ |
2022 | IQVIA Reports Second-Quarter 2022 Results | BU |
2022 | IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022 | BU |
2022 | IQVIA Recognized as a Leader in Life Science Sales and Marketing IT Outsourcing Service.. | BU |
2022 | Iqvia Holdings Inc. : Entry into a Material Definitive Agreement, Creation of a Direct Fin.. | AQ |
2022 | IQVIA Appoints Dr. Christina Mack Chief Scientific Officer of Real World Solutions | BU |
2022 | Global Oncology R&D Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for.. | BU |
2022 | IQVIA CFO Ron Bruehlman to Speak at Jefferies Healthcare Conference on June 10, 2022 | BU |
2022 | IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
2022 | Iqvia : Q1 Earnings Snapshot | AQ |
2022 | Iqvia : Reports First-Quarter 2022 Results - Form 8-K | PU |
2022 | IQVIA Reports First-Quarter 2022 Results | BU |
2022 | Spending on U.S. Medicines Rose 12% in 2021 Due to COVID-19 Vaccines and Therapies, Say.. | BU |
2022 | Iqvia Holdings Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Sub.. | AQ |
2022 | IQVIA to Announce First-Quarter 2022 Results on April 27, 2022 | BU |
2022 | IQVIA Selected to Support EMA's DARWIN EU® Coordination Centre Initiative | BU |
2022 | IQVIA Launches OCE+ To Deliver Enhanced AI-Driven Customer Engagement | BU |
2022 | Iqvia : Appoints Costa Panagos President of Research & Development Solutions (R&DS) - Form.. | PU |
2022 | Iqvia Holdings Inc. : Change in Directors or Principal Officers, Financial Statements and .. | AQ |
2022 | IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS) | BU |
2022 | IQVIA CFO to Speak at Barclays Global Healthcare Conference on March 16, 2022 | BU |
2022 | IQVIA selected to accelerate clinical development of VYVGART™ (efgartigimod alfa .. | BU |
2022 | IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey | BU |
2022 | IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report | BU |
2022 | IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
2022 | Iqvia : Q4 Earnings Snapshot | AQ |
2022 | Iqvia : Reports Fourth-Quarter and Full-Year 2021 Results; Raises Full-Year 2022 Profit Gu.. | PU |
2022 | IQVIA Reports Fourth-Quarter and Full-Year 2021 Results; Raises Full-Year 2022 Profit G.. | BU |
2022 | IQVIA CFO Ron Bruehlman to Speak at Citi's 2022 Virtual Healthcare Conference on Februa.. | BU |
2022 | Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to N.. | BU |
2022 | Iqvia Named To Fortune's 2022 List O : Pharmacy and Other Services | BU |
2022 | IQVIA to Announce Fourth-Quarter and Full-Year 2021 Results on February 15, 2022 | BU |
2022 | Iqvia : Leslie Wims Morris Joins IQVIA Board of Directors - Form 8-K | PU |
2022 | Iqvia Holdings Inc. : Change in Directors or Principal Officers, Regulation FD Disclosure,.. | AQ |
2022 | Sheila A. Stamps Joins IQVIA Board of Directors | BU |
2022 | Leslie Wims Morris Joins IQVIA Board of Directors | BU |
2021 | Iqvia : OneKey Powers Precision Targeting | PU |
2021 | Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19.. | BU |
2021 | ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration | AQ |
2021 | IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Service.. | BU |
2021 | IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and Marketing | BU |
2021 | IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engag.. | BU |